Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RBR-4n26tfPhase 4Recruiting
Phase 4, randomised, open-label trial in asthma (5 arms), sponsored by Universidade Federal do Paraná. Primary endpoints: Bronchodilator activity by pulmonary function testing and Anti-inflammatory activity by pulmonary function testing. Started Jul 2016; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on RBR-4n26tf.